PFM Health Sciences’s Activision Blizzard ATVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-4,226
Closed -$197K 126
2018
Q4
$197K Sell
4,226
-386,108
-99% -$23.1M 0.01% 94
2018
Q3
$32.5M Sell
390,334
-162,325
-29% -$12.3M 0.48% 73
2018
Q2
$42.2M Buy
552,659
+12,405
+2% +$878K 0.66% 60
2018
Q1
$36.4M Sell
540,254
-155,897
-22% -$11M 0.74% 55
2017
Q4
$44.1M Sell
696,151
-411,753
-37% -$26M 1.05% 42
2017
Q3
$71.5M Buy
1,107,904
+614,128
+124% +$38.3M 1.4% 24
2017
Q2
$28.4M Buy
+493,776
New +$27.3M 0.77% 45

Other funds holding ATVI

PFM Health Sciences's ATVI Position: Q1 2019 in Review

PFM Health Sciences sold out of Activision Blizzard (ATVI) in Q1 2019, closing a stake of 4,226 shares — an estimated $197K sold.

PFM Health Sciences first reported a position in ATVI in Q2 2017 and held it in 7 quarters. The position peaked at $71.5M in Q3 2017. 828 funds tracked by Wall St. Rank hold ATVI as of Q1 2019.

  • PFM Health Sciences reported no remaining Activision Blizzard position as of Q1 2019 after selling out during the quarter.
  • PFM Health Sciences sold 4,226 Activision Blizzard shares in Q1 2019, an estimated $197K.
  • PFM Health Sciences first reported a position in Activision Blizzard in Q2 2017 and held it in 7 quarters.
  • PFM Health Sciences's Activision Blizzard position peaked at $71.5M in Q3 2017.
  • 828 funds tracked by Wall St. Rank held Activision Blizzard as of Q1 2019.

Based on PFM Health Sciences's 13F filing for Q1 2019, filed 15 May 2019.